Circular RNAs in Metabolic Diseases

Area of Science:

• Molecular Biology
• Genetics
• Endocrinology

Background:

• Rising global prevalence of metabolic diseases including obesity, metabolic syndrome (MetS), non-alcoholic fatty liver disease (NAFLD), and diabetes mellitus (DM).
• Underlying pathogenic mechanisms of these metabolic diseases remain incompletely understood.
• Emerging evidence suggests circular RNAs (circRNAs) play regulatory roles in metabolic disease mechanisms.

Purpose of the Study:

• To review and highlight the role of circRNAs in the pathogenesis of metabolic diseases.
• To specifically focus on circRNAs implicated in the metabolic syndrome (MetS), an area with limited research.
• To consolidate current knowledge on circRNAs in obesity, NAFLD, and DM pathogenesis.

Main Methods:

• Literature review of studies investigating the role of circRNAs in metabolic diseases.
• Analysis of research focusing on circRNAs in obesity, NAFLD, DM, and MetS.
• Synthesis of findings to highlight the relevance of circRNAs in disease pathogenesis.

Main Results:

• Multiple studies demonstrate the involvement of circRNAs in the pathogenesis of obesity, NAFLD, and DM.
• A growing body of evidence points to circRNAs as key regulators in these metabolic conditions.
• Research specifically on circRNAs in MetS is less extensive but indicates significant relevance.

Conclusions:

• CircRNAs are increasingly recognized as critical regulators in the development of metabolic diseases.
• Further investigation into circRNAs, particularly in the context of MetS, is warranted.
• Understanding circRNA functions may offer novel therapeutic targets for metabolic disorders.